A phase i trial of the met/alk/ros1 inhibitor crizotinib combined with the vegf inhibitor pazopanib in patients with advanced solid malignancies
- Sarina A. Piha-Paul
- , Ecaterina E. Dumbrava
- , Binoj C. Nair
- , Wendy Xiong
- , Li Xu
- , Rosa Mostorino
- , Vivek Subbiah
- , Nizar Tannir
- , Siqing Fu
- , Aung Naing
- , Filip Janku
- , Daniel D. Karp
- , Shreyaskumar Patel
- , Najat C. Daw
- , David Hong
- , Funda Meric-Bernstam
- , Ralph Zinner
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations